CVE:VM Voyageur Pharmaceuticals (VM) Stock Price, News & Analysis → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free VM Stock Alerts C$0.05 -0.01 (-9.09%) (As of 04/26/2024 05:33 PM ET) Add Compare Share Share Today's RangeC$0.05▼C$0.0550-Day RangeC$0.05▼C$0.0952-Week RangeC$0.04▼C$0.09Volume63,500 shsAverage Volume98,731 shsMarket CapitalizationC$6.94 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Voyageur Pharmaceuticals alerts: Email Address Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide About Voyageur Pharmaceuticals Stock (CVE:VM)Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.Read More VM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VM Stock News HeadlinesMarch 13, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals executes royalty agreement with Rain Cage CarbonJanuary 3, 2024 | morningstar.comVoyageur Pharmaceuticals Ltd VMApril 27, 2024 | DTI (Ad)If you have $2,500 bucks… check this out This computer whiz has been averaging 234% per year with an undefeated strategy he calls… The “Income Glitch” And he’s been making out like a bandit with a 100% success rate on over 64 trade opportunities! December 21, 2023 | stockhouse.comVoyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to DirectorsDecember 8, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Thursday (VM)October 24, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Monday (VM)September 14, 2023 | stockhouse.comVoyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast MediaSeptember 14, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals achieves milestone developing HDXBa barium contrast mediaApril 27, 2024 | DTI (Ad)If you have $2,500 bucks… check this out This computer whiz has been averaging 234% per year with an undefeated strategy he calls… The “Income Glitch” And he’s been making out like a bandit with a 100% success rate on over 64 trade opportunities! September 7, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Wednesday (VM)June 20, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Tuesday (VM)May 31, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals completes field work at Frances Creek project in British ColumbiaMay 24, 2023 | finance.yahoo.comVoyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast DrugsMay 24, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals unveils pioneering agreement with Rain Cage CarbonMay 10, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Tuesday (VM)May 4, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Wednesday (VM)May 2, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Monday (VM)April 29, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Friday (VM)April 28, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Thursday (VM)April 26, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Monday (VM)April 22, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Friday (VM)April 21, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Thursday (VM)April 14, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Friday (VM)April 8, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Wednesday (VM)April 6, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Tuesday (VM)April 4, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals reports positive comparative study of SmoothX barium contrast media for CT imagingFebruary 14, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals preparing to launch sales of its first product in CanadaSee More Headlines Receive VM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:VM CUSIPN/A CIKN/A Webwww.voyageurminerals.ca Phone587-779-6166FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-1,400,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-96.50% Return on Assets-35.90% Debt Debt-to-Equity Ratio2.79 Current Ratio0.13 Quick Ratio0.84 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.00 per share Price / Cash Flow35.00 Book ValueC$0.01 per share Price / Book5.00Miscellaneous Outstanding Shares138,810,000Free FloatN/AMarket CapC$6.94 million OptionableNot Optionable Beta0.49 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Brent Willis Bsc.Eng (Age 53)President, CEO & Director Comp: $131kMr. Bradley Craig Willis P.Eng. (Age 53)Founder, COO & Director Comp: $125.5kMr. Albert DeslauriersChief Financial OfficerKey CompetitorsAleafia HealthTSE:AHCrescita TherapeuticsTSE:CTXHarvest One CannabisCVE:HVTKhiron Life SciencesCVE:KHRNLattice BiologicsCVE:LBLView All Competitors VM Stock Analysis - Frequently Asked Questions How have VM shares performed in 2024? Voyageur Pharmaceuticals' stock was trading at C$0.08 on January 1st, 2024. Since then, VM shares have decreased by 33.3% and is now trading at C$0.05. View the best growth stocks for 2024 here. What other stocks do shareholders of Voyageur Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Voyageur Pharmaceuticals investors own include Agile Therapeutics (AGRX), Sierra Oncology (SRRA), Achillion Pharmaceuticals (ACHN), LINE (LN), Littelfuse (LFUS), Howard Hughes (HHC), EQT (EQT), Deckers Outdoor (DECK), Cranswick (CWK) and Cirrus Logic (CRUS). How do I buy shares of Voyageur Pharmaceuticals? Shares of VM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:VM) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyageur Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
